Oritavancin on the Results of Multiple Coagulation Tests in Healthy Volunteers

NCT02357524 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Oritavancin

Sponsor

Melinta Therapeutics, Inc.

Collaborators

[object Object]